logo

BHST

BioHarvest Sciences
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

Key Stats

--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

About BHST

Bioharvest Sciences Inc.

A biotechnology company that has developed plant synthesis platform technology

Pharmaceutical
04/19/2013
11/12/2024
NASDAQ Stock Exchange
87
12-31
Common stock
1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada
--
BioHarvest Sciences Inc., was incorporated in British Columbia, Canada on April 19, 2013. The company is a biotechnology company that develops plant synthesis platform technology that enables the company to grow the active and beneficial ingredients in certain fruits and plants on an industrial scale in a bioreactor without growing the plants themselves. The plant synthesis platform technology is the only non-GMO platform that can produce plant cells with significantly higher concentrations of active ingredients and extremely high solubility and bioavailability compared to naturally produced cells. The plant synthesis platform is technically affordable, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture by providing consistent product production, year-round production cycles, and products that are free of sugar, calories, and pollutants (such as pesticides, heavy metals, and residues).

Company Financials

Revenue & Expenses

BHST has released its 2024 Q4 earnings report, with revenue of 7.28M, reflecting a YoY change of 61.02%, and net profit of -2.96M, showing a YoY change of 59.14%. The Sankey diagram below clearly presents BHST’s revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime